Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kristin Marissa Galetta, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Conway SE, Pua DKA, Holroyd KB, Galetta K, Bhattacharyya S. Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors. Mult Scler. 2023 Mar; 29(3):471-474. PMID: 35957594.
    Citations:    Fields:    Translation:Humans
  2. Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T. Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Mult Scler Relat Disord. 2022 Nov; 67:104079. PMID: 35952457; PMCID: PMC9330583.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  3. Howard D, Galetta K. Rethinking the algorithm for fatigue management in MS-how the placebo effect can confound clinical expertise. Mult Scler Relat Disord. 2022 09; 65:104021. PMID: 35810722.
    Citations:    Fields:    Translation:Humans
  4. Galetta K, Ryan S, Manzano G, Chibnik LB, Balaban D, Prasad S, Chwalisz BK, Salazar-Camelo A, Conway S, Levy M, Matiello M. Treatment outcomes of first-ever episode of severe optic neuritis. Mult Scler Relat Disord. 2022 Oct; 66:104020. PMID: 35839615.
    Citations:    Fields:    Translation:Humans
  5. Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK. COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Mult Scler Relat Disord. 2022 Jul; 63:103946. PMID: 35709663; PMCID: PMC9556032.
    Citations: 2     Fields:    Translation:Humans
  6. Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series. Mult Scler Relat Disord. 2022 Jul; 63:103861. PMID: 35576727.
    Citations:    Fields:    Translation:HumansCells
  7. Galetta K, Bhattacharyya S. Acute Neurologic Manifestations of Systemic Immune-Mediated Diseases. Semin Neurol. 2021 10; 41(5):541-553. PMID: 34619780.
    Citations:    Fields:    Translation:Humans
  8. Rice DR, Kaplan TB, Hotan GC, Vogel AC, Matiello M, Gillani RL, Hutto SK, Ham AS, Klawiter EC, George IC, Galetta K, Mateen FJ. Electronic pill bottles to monitor and promote medication adherence for people with multiple sclerosis: A randomized, virtual clinical trial. J Neurol Sci. 2021 09 15; 428:117612. PMID: 34392138.
    Citations: 1     Fields:    Translation:Humans
  9. Bose G, Galetta K. Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis. Mult Scler Relat Disord. 2021 Jul; 52:102922. PMID: 33895693; PMCID: PMC7992302.
    Citations: 7     Fields:    Translation:HumansCells
  10. Galetta K, Deshpande C, Healy BC, Glanz B, Ziehn M, Saxena S, Paul A, Saleh F, Collins M, Gaitan-Walsh P, Castro-Mendoza P, Weiner HL, Chitnis T. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis. Ann Clin Transl Neurol. 2021 03; 8(3):631-638. PMID: 33492760.
    Citations: 4     Fields:    Translation:Humans
  11. Galetta K, Gheihman G, Rosen A, Klein JP, Bhattacharyya S. Influence of Autoimmune Antibody Testing on the Use of Immunotherapy on an Inpatient Neurology Service. Neurohospitalist. 2021 Jul; 11(3):214-220. PMID: 34163547; PMCID: PMC8182399.
    Citations: 3     
  12. Carlisle TC, Galetta KM, McGinnis SM, Bockow Kaplan T. Clinical Reasoning: A 58-year-old woman presents with progressive memory deficits, odd behavior, and falls. Neurology. 2020 02 04; 94(5):e557-e561. PMID: 31959711.
    Citations:    Fields:    Translation:Humans
  13. Kaplan TB, Bove R, Galetta K, Healy B, Chitnis C, Houtchens M. Effect of pregnancy loss on MS disease activity. J Neurol Sci. 2019 Feb 15; 397:58-60. PMID: 30590343.
    Citations: 2     Fields:    Translation:Humans
  14. Galetta KM, Bhattacharyya S. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System. Med Clin North Am. 2019 Mar; 103(2):325-336. PMID: 30704684.
    Citations: 10     Fields:    Translation:Humans
  15. Galetta KM, Prasad S. Historical Trends in the Diagnosis of Peduncular Hallucinosis. J Neuroophthalmol. 2018 12; 38(4):438-441. PMID: 29215387.
    Citations: 4     Fields:    Translation:Humans
  16. Vedula R, Vaidya A, Galetta K, Laubach J. A Sticky Situation. N Engl J Med. 2018 Sep 27; 379(13):e22. PMID: 30257165.
    Citations:    Fields:    Translation:Humans
  17. Galetta KM, Chapman KR, Essis MD, Alosco ML, Gillard D, Steinberg E, Dixon D, Martin B, Chaisson CE, Kowall NW, Tripodis Y, Balcer LJ, Stern RA. Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):152-158. PMID: 27299935.
    Citations: 21     Fields:    Translation:Humans
  18. Sabadia SB, Nolan RC, Galetta KM, Narayana KM, Wilson JA, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ. 20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought? J Neuroophthalmol. 2016 12; 36(4):369-376. PMID: 27472185.
    Citations: 14     Fields:    Translation:HumansCells
  19. Gilden D, White T, Boyer PJ, Galetta KM, Hedley-Whyte ET, Frank M, Holmes D, Nagel MA. Varicella Zoster Virus Infection in Granulomatous Arteritis of the Aorta. J Infect Dis. 2016 06 15; 213(12):1866-71. PMID: 27037084; PMCID: PMC4878728.
    Citations: 17     Fields:    Translation:HumansCells
  20. Galetta KM, Gilden D. Zeroing in on zoster: A tale of many disorders produced by one virus. J Neurol Sci. 2015 Nov 15; 358(1-2):38-45. PMID: 26454371; PMCID: PMC4628852.
    Citations: 7     Fields:    Translation:HumansCells
  21. Galetta KM, Liu M, Leong DF, Ventura RE, Galetta SL, Balcer LJ. The King-Devick test of rapid number naming for concussion detection: meta-analysis and systematic review of the literature. Concussion. 2016 Mar; 1(2):CNC8. PMID: 30202552; PMCID: PMC6114024.
    Citations: 28     
  22. Galetta KM, Morganroth J, Moehringer N, Mueller B, Hasanaj L, Webb N, Civitano C, Cardone DA, Silverio A, Galetta SL, Balcer LJ. Adding Vision to Concussion Testing: A Prospective Study of Sideline Testing in Youth and Collegiate Athletes. J Neuroophthalmol. 2015 Sep; 35(3):235-41. PMID: 25742059.
    Citations: 39     Fields:    Translation:Humans
  23. Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M. Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results. Neurology. 2015 Jun 16; 84(24):2449-56. PMID: 25995055; PMCID: PMC4478032.
    Citations: 23     Fields:    Translation:Humans
  24. Marinides Z, Galetta KM, Andrews CN, Wilson JA, Herman DC, Robinson CD, Smith MS, Bentley BC, Galetta SL, Balcer LJ, Clugston JR. Vision testing is additive to the sideline assessment of sports-related concussion. Neurol Clin Pract. 2015 Feb; 5(1):25-34. PMID: 29443175; PMCID: PMC5764425.
    Citations: 20     
  25. Torres DM, Galetta KM, Phillips HW, Dziemianowicz EM, Wilson JA, Dorman ES, Laudano E, Galetta SL, Balcer LJ. Sports-related concussion: Anonymous survey of a collegiate cohort. Neurol Clin Pract. 2013 Aug; 3(4):279-287. PMID: 24195017.
    Citations: 51     
  26. Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, Wilmot GR, Gomez CM, Ravina B, Zesiewicz T, Bushara KO, Subramony SH, Ashizawa T, Delatycki MB, Brocht A, Balcer LJ, Lynch DR. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013 Sep; 260(9):2362-9. PMID: 23775342.
    Citations: 23     Fields:    Translation:Humans
  27. Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, Talman LS, Galetta KM, Shumski MJ, Wilson J, Ford E, Lavery AM, Conger D, Greenberg BM, Ellenberg JH, Frohman EM, Balcer LJ, Calabresi PA. Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. Mult Scler Relat Disord. 2013 May 01; 3(3):326-334. PMID: 24683535.
    Citations: 16     Fields:    
  28. Galetta MS, Galetta KM, McCrossin J, Wilson JA, Moster S, Galetta SL, Balcer LJ, Dorshimer GW, Master CL. Saccades and memory: baseline associations of the King-Devick and SCAT2 SAC tests in professional ice hockey players. J Neurol Sci. 2013 May 15; 328(1-2):28-31. PMID: 23499425.
    Citations: 35     Fields:    Translation:Humans
  29. Galetta KM, Balcer LJ. Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials. Mult Scler Relat Disord. 2013 Jul; 2(3):172-82. PMID: 25877723.
    Citations: 11     Fields:    
  30. Galetta KM, Graves J, Talman LS, Lile DJ, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ. Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. J Neuroophthalmol. 2012 Jun; 32(2):116-23. PMID: 22269944.
    Citations: 14     Fields:    Translation:HumansCells
  31. Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012 Jun; 119(6):1250-7. PMID: 22365058.
    Citations: 133     Fields:    Translation:HumansCells
  32. Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol. 2011 Dec; 31(4):362-73. PMID: 22089500.
    Citations: 54     Fields:    Translation:HumansCells
  33. Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol. 2011 Sep; 31(3):260-4. PMID: 21654523.
    Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
  34. Galetta KM, Brandes LE, Maki K, Dziemianowicz MS, Laudano E, Allen M, Lawler K, Sennett B, Wiebe D, Devick S, Messner LV, Galetta SL, Balcer LJ. The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci. 2011 Oct 15; 309(1-2):34-9. PMID: 21849171.
    Citations: 64     Fields:    Translation:Humans
  35. Galetta KM, Barrett J, Allen M, Madda F, Delicata D, Tennant AT, Branas CC, Maguire MG, Messner LV, Devick S, Galetta SL, Balcer LJ. The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology. 2011 Apr 26; 76(17):1456-62. PMID: 21288984; PMCID: PMC3087467.
    Citations: 71     Fields:    Translation:Humans
  36. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics. 2011 Jan; 8(1):117-32. PMID: 21274691.
    Citations: 67     Fields:    Translation:Humans
  37. Talman LS, Bisker ER, Sackel DJ, Long DA, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010 Jun; 67(6):749-60. PMID: 20517936.
    Citations: 155     Fields:    Translation:HumansCells
  38. Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006 Dec; 142(6):1026-35. PMID: 17046704.
    Citations: 48     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Galetta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (148)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.